PAXMYRNA
Live / Applied — Second extension granted (statement of use) (as of 04 Nov 2025)
What this means for you
Not registered yet, but its 08 Mar 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98440101
- Mark type
- Stylized text
- Filed
- 08 Mar 2024
- Published for opposition
- 29 Oct 2024
- Attorney of record
- Alexandra Kochian
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, pharmaceutical preparations for use in immunology, antibodies for medical use; vaccines
Owner
- Sanofi Pasteur Inc., Swiftwater, PA, US
- Sanofi Pasteur Inc., Swiftwater, PA, US
Prosecution history
- 05 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Nov 2025 — SOU EXTENSION 2 GRANTED
- 04 Nov 2025 — SOU EXTENSION 2 FILED
- 04 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Apr 2025 — SOU EXTENSION 1 GRANTED
- 17 Apr 2025 — SOU EXTENSION 1 FILED
- 17 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Oct 2024 — PUBLISHED FOR OPPOSITION